SCHEMBL17372249

SCHEMBL17372249

CCOc1cn([C@H]2O[C@@H](CO)C(O)C2O)c(=O)[nH]c1=O

nearest known ligand 0.63

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PYGM P11217 3/20 0.63
TK2 O00142 3/20 0.58
SLC28A1 O00337 1/20 0.54
SLC28A2 O43868 1/20 0.54
SLC29A1 Q99808 1/20 0.54
SLC28A3 Q9HAS3 1/20 0.54
P2RY6 Q15077 7/20 0.52
DNPH1 O43598 1/20 0.50
P2RY2 P41231 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16152125 1.00 PYGM (0.63) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL16152124 0.90 PYGM (0.60) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL41141 0.88 PYGM (0.66) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL17012263 0.88 PYGM (0.66) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL41142 0.88 PYGM (0.66) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL14853822 0.88 PYGM (0.66) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL22028243 0.86 PYGM (0.67) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL2754231 0.86 PYGM (0.71) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL2754232 0.86 PYGM (0.71) PYGMTK2SLC28A1SLC28A2SLC29A1
SCHEMBL600801 0.86 PYGM (0.64) PYGMTK2SLC28A1SLC28A2SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3157573-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2017-04-26 EP disclosed
WO-2015196128-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO disclosed
US-9012453-B2 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia H. LUNDBECK A/S (DK) 2015-04-21 US disclosed